A Phase 2 Randomized, Placebo-controlled Study of the Safety and Efficacy of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection.

Experiencing a runny nose, cough, congestion, or wheezing? RSV might be the culprit, and a quick test can confirm. Take action, contact us today about a clinical trial, and help fight back against RSV.

No Cost RSV testing. See if you qualify for a clinical trial.

RSV can be a serious, life-threatening virus for high-risk adults who are 18 years or older and meet at least 1 of the following criteria: • Moderate or severe COPD • Asthma • Chronic lung disease • Chronic cardiovascular disease • ≥60 years of age (vaccinated or nonvaccinated).

Why join an RSV clinical trial? • Access to an investigational oral medication for RSV • Limited treatment options for high-risk adults • No FDA-approved oral treatment available • Don’t have to discontinue current medications to participate